Cannabis Sativa, Inc. Signs Deal Offering "hi BENEFITS" Discount Pharmacy Card
MESQUITE, NV / ACCESSWIRE / September 25, 2015 / Cannabis Sativa Inc (PINKSHEETS: CBDS) is proud to announce that its wholly owned subsidiary, "HI Brands International, Inc." ("HBI"), a Nevada corporation, has entered into a strategic joint venture with the developer of a pharmacy discount card to distribute the card under its "HI" brand to be marketed as the "HI BENEFITS Discount Pharmacy Card." The HI BENEFITS card will be offered throughout the U.S. and internationally. The card has no health restrictions, and everyone qualifies for this easy to use card with no fees ever and no paperwork to file with insurance companies. HBI has the exclusive right to distribute the HI BENEFITS card in certain specified market segments and the non-exclusive rights outside those specified markets.
The HI BENEFITS Discount Pharmacy Card offers unlimited use with any pharmacy in the network. The HI BENEFITS card never expires and will be instantly activated. HI BENEFITS discount pharmacy card membership is free because there is no need for a physical card, a member simply uses a jpg image on their smartphone or can print a card at home. Simply present the card to the pharmacist and save 10% - 70% on prescriptions. The HI BENEFITS Discount Pharmacy Card will continue to add more benefits for its users.
CEO Gary Johnson said "This is an opportunity for our Company to offer a loyalty program that saves the members money while at the same time producing a revenue stream for CBDS."
The Company expects the HI BENEFITS DISCOUNT PHARMACY CARD to be operational in October, 2015
About CBDS: Cannabis Sativa, Inc. is in the business of branding and licensing via its 'hi' intellectual properties. The Company also offers the Wild Earth Naturals line of CBD Water and cosmetic products which are designed to use organic and natural ingredients, including CBD and Hemp Seed Oil. The Company is engaged through its subsidiaries, Kush and Hi Brands International, Inc., in the research, development and licensing of specialized natural cannabis products, including cannabis formulas, edibles, topicals, strains, recipes and delivery systems.
This news release contains "forward-looking statements." Although the forward-looking statements in this release reflect the good faith judgment of management, forward-looking statements are inherently subject to known and unknown risks and uncertainties that may cause actual results to be materially different from those discussed in these forward-looking statements. Readers are urged to carefully review and consider the various disclosures made by us in our reports filed with the Securities and Exchange Commission, including the risk factors that attempt to advise interested parties of the risks that may affect our business, financial condition, results of operation and cash flows. If one or more of these risks or uncertainties materialize, or if the underlying assumptions prove incorrect, our actual results may vary materially from those expected or projected. Readers are urged not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. We assume no obligation to update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this release.
Cannabis Sativa, Inc (c/o Investor Relations)
PO Box 1602 Mesquite, NV 89027
SOURCE: Cannabis Sativa, Inc.